title: Demonstration of the cell cycle positions of taxol-induced "asters" and "bundles" by sequential measurements of tubulin immunofluorescence, DNA content, and autoradiographic labeling of taxol-sensitive and -resistant cells.
abstract: We used reliable and relatively inexpensive equipment to make sequential sets of measurements of antitubulin immunofluorescence, Feulgen staining, and autoradiography on the same cells. This was done to evaluate tubulin conformations, DNA content, and [3H]-thymidine incorporation in cell lines sensitive (HL60) and resistant (K562) to the novel anti-tubulin chemotherapeutic agent taxol. Numbers of cells with microtubule bundles have been found to correlate with sensitivity to taxol by clonogenic assay for several leukemic cell lines. We have found that cells with "asters" produced by taxol exposure are in mitosis and that cells with taxol-induced "bundles" are in G0/G1, S, and G2 phases. We further found that S-phase cells with microtubule bundles in both sensitive (HL60) and resistant (K562) cell lines were able to incorporate [3H]-thymidine after 4-hr exposure to taxol. As microtubule bundles and asters occur in cells of the same cell cycle phases in both lines, we conclude that the greater frequency of cells with microtubule bundles reported for sensitive cells after taxol treatment cannot result from drug exclusion nor from different effects of the drug on cell microtubules in these two leukemic lines.
authors.affiliation: Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland 21205.
authors.forename: J R
authors.initials: JR
authors.lastname: Roberts
authors.forename: E K
authors.initials: EK
authors.lastname: Rowinsky
authors.forename: R C
authors.initials: RC
authors.lastname: Donehower
authors.forename: J
authors.initials: J
authors.lastname: Robertson
authors.forename: D C
authors.initials: DC
authors.lastname: Allison
mesh_terms: D000470:Alkaloids / Q000494:pharmacology*; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D001345:Autoradiography; D002453:Cell Cycle / Q000187:drug effects; D002460:Cell Line; D004247:DNA / Q000032:analysis* / Q000378:metabolism; D004351:Drug Resistance; D005455:Fluorescent Antibody Technique; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism / Q000473:pathology*; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism / Q000473:pathology*; D008854:Microscopy, Electron; D008870:Microtubules / Q000187:drug effects* / Q000378:metabolism; D008938:Mitosis; D017239:Paclitaxel; D013936:Thymidine / Q000378:metabolism; D014404:Tubulin / Q000378:metabolism*
chemical_list: D000470:Alkaloids; D000972:Antineoplastic Agents, Phytogenic; D014404:Tubulin; D004247:DNA; D017239:Paclitaxel; D013936:Thymidine